AZACITIDINE ACCORD 25 mg/ml, powder for injectable suspension bottle, CIP 3400930195970
Active ingredients: Azacitidine
Commercialized according to BDPMDispensing in France: Prescription only
Powder for injectable suspensionbottle, CIP 3400930195970sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AZACITIDINE ACCORD 25 mg/mL, poudre pour suspension injectable
- Pharmaceutical form
- poudre pour suspension injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 100 mg
- Marketing authorisation holder
- ACCORD HEALTHCARE (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Apr 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65953669CIP73019597CIP133400930195970Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AZACITIDINEpoudre | 25 mg · 1 mL de suspension reconstituée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.